Cantharidin Application in Molluscum Patients
Public ClinicalTrials.gov record NCT03377803. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Pivotal Study to Evaluate the Safety and Efficacy of VP-102 Topical Film-Forming Solution [0.7% (w/v) Cantharidin] in Subjects (2 Years and Older) With Molluscum Contagiosum
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is a Phase 3, randomized, double-blind, placebo-controlled, pivotal study to evaluate the safety and efficacy of VP-102 topical film-forming solution in subjects with Molluscum Contagiosum. VP-102 will be applied once every 21 days for up to 4 applications, to treatable molluscum contagiosum (molluscum) lesions on subjects 2 years and older. Efficacy will be assessed as the proportion of subjects achieving complete clearance of all treatable molluscum lesions (baseline and new) on the Day 84 visit.
Study identification
- NCT ID
- NCT03377803
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 262 participants
Conditions and interventions
Conditions
Interventions
- VP-102 - Cantharidin, Topical Film Forming Solution Combination Product
- Placebo -Topical Film Forming Solution without VP-102 Combination Product
Combination Product
Eligibility (public fields only)
- Age range
- 2 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 14, 2018 (Actual)
- Primary completion
- Sep 26, 2018 (Actual)
- Completion
- Sep 26, 2018 (Actual)
- Last update posted
- Dec 14, 2021
2018
United States locations
- U.S. sites
- 15
- U.S. states
- 9
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Bakersfield Dermatology | Bakersfield | California | 93309 | — |
| Rady Children's Hospital | San Diego | California | 92123 | — |
| Redwood Family Dermatology | Santa Rosa | California | 95403 | — |
| Solution Through Advanced Research | Jacksonville | Florida | 32256 | — |
| Lenus Research and Medical Group | Sweetwater | Florida | 33172 | — |
| Northwestern Memorial Hospital | Chicago | Illinois | 60611 | — |
| Dermatology Center of Northwestern Indiana | Crown Point | Indiana | 46307 | — |
| Pedia Research | Evansville | Indiana | 47715 | — |
| Pedia Research | Owensboro | Kentucky | 42301 | — |
| Hamzavi Dermatology | Fort Gratiot | Michigan | 48059 | — |
| Midwest Children's Health-Northwoods | Lincoln | Nebraska | 68505 | — |
| Midwest Children's Health | Lincoln | Nebraska | 68505 | — |
| Tekton Research | Austin | Texas | 78745 | — |
| DCOL Center for Clinical Research | Longview | Texas | 75605 | — |
| The Education and Research Foundation | Lynchburg | Virginia | 24501 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03377803, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 14, 2021 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03377803 live on ClinicalTrials.gov.